Stay updated on Tisotumab Vedotin Safety in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added. The notice about government funding lapse and Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a glossary display and updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and revision 3.4.0, while removing the older Last Update Submitted that met QC Criteria, No FEAR Act data, and revision 3.3.4.SummaryDifference0.2%

- Check35 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing Revision: v3.3.3; this is a small metadata update with no impact on the study content.SummaryDifference0.0%

- Check64 days agoChange DetectedNew study locations were added across several regions, including Texas (USA), Brussels Capital, Flemish Brabant, Hainaut, Liège, and Namur in Belgium, Győr-Moson-Sopron and Hajdú-Bihar in Hungary, and England. Some previous location groupings were removed, and the study page revision updated from v3.3.2 to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.8%

- Check85 days agoChange DetectedRevision notes show a new version: v3.3.2 added and v3.3.1 removed; no changes to the visible study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tisotumab Vedotin Safety in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Safety in Solid Tumors Clinical Trial page.